Blood Flow Restriction Therapy to Optimize Muscle Size and Strength in Recovery From Lower Limb Fractures

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19-60
SponsorUniversity of British Columbia

About this trial

This study will assess the feasibility and effectiveness of blood flow restriction therapy in patients with tibia fractures (or lower leg bone). Personalized blood flow restriction therapy has shown to help people regain muscle size and strength after surgical treatment by allowing them to be able to start physiotherapy on their injured leg sooner. This study aims to evaluate the feasibility and effectiveness of personalized blood flow restriction therapy to improve thigh muscle size and strength in patients with lower limb tibia fractures which require a period of non-weightbearing.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients aged 19-60 who have sustained an isolated (single bone/area as per AO/OTA classification) unilateral lower limb fracture of the tibia that requires a period of 6 weeks of protected weight bearing (non-weight bearing or toe touch weight bearing)

Must speak English

Must be able to comply with protected weight bearing instructions for at least 6 weeks

Must be able to consent for inclusion into the trial

Disqualifiers

Patients who have sustained multiple fractures in the same limb (i.e. AO/OTA 3 and 4, or 4 and 8 etc).

Patients who have a neurovascular injury associated with the fracture

Patients who have sustained bilateral lower limb injuries

Patients aged <19 and >60

Trial design

Design model

Parallel

Treatments tested in this trial

  • Blood Flow Restriction Therapy

    Other intervention

    Personalized Blood Flow Restriction Therapy uses an an inflatable cuff (Delfi PTS system) around the upper thigh which partially restricts arterial inflow during exercise. BFR allows for similar improvements of muscular strength and muscle mass as traditional heavy load strength training while using significantly lower loads. The reduced stress on supporting tissues ( tendons, joints, bones and ligaments) allows people who normally couldn't tolerate high loads to enhance their strength and muscle mass.

Treatment groups

20 Participants
are divided into 2 treatment groups
Group A: ControlNo intervention 0 interventions
Group B: Blood Flow Restriction Therapy (BFRT)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Number of participants who consent to participate

Percentage of participants approached for recruitment who consent to study participation

Time frame
12 weeks
2

Number of participants self-reporting adherence to treatment protocol

Percentage of participants enrolled in the study who report to completing their prescribed post injury physiotherapy sessions

Time frame
12 weeks
3

Number of participants missing data on regular assessment

Percentage of participants with missing data on regular assessment

Time frame
12 weeks
4

Number of participants who withdraw from the study

Percentage of participants enrolled in the study who withdraw before completion of the study

Time frame
12 weeks

Secondary outcomes

Other outcomes

1

Limb Occlusion Pressure (LOP) in millimeters of mercury (mmHg)

Participants' maximum percentage of Limb Occlusion Pressure (LOP) in millimeters of mercury (mmHg) at which all exercises could be completed

Time frame
0, 2, 6, 12 weeks post injury/surgery
2

Number of participants with incomplete Limb Occlusion Pressure (LOP)

Number of participants who could not complete the exercises at any percentage of Limb Occlusion Pressure (LOP)

Time frame
0, 2, 6, 12 weeks post injury/surgery

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of British Columbia

Lead sponsor

AO North America

Collaborator

This trial is not recruiting at the moment. You can still explore other options: